Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

Anthony A. Portale, Karl Insogna, Thomas O. Carpenter et al.|Calcified Tissue International|2019

Cited by 160